Cargando…
Tissue Plasminogen Activator Use in Cardiac Arrest Secondary to Fulminant Pulmonary Embolism
BACKGROUND: Tissue plasminogen activator (tPA) is used emergently to dissolve thrombi in the treatment of fulminant pulmonary embolism. Currently, there is a relative contraindication to tPA in the setting of traumatic or prolonged cardiopulmonary resuscitation > 10 minutes because of the risk of...
Autores principales: | Yousuf, Tariq, Brinton, Taylor, Ahmed, Khansa, Iskander, Joy, Woznicka, Daniel, Kramer, Jason, Kopiec, Adam, Chadaga, Amar R., Ortiz, Kathia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737028/ https://www.ncbi.nlm.nih.gov/pubmed/26858790 http://dx.doi.org/10.14740/jocmr2452w |
Ejemplares similares
-
In Search for Equilibrium: Immunosuppression Versus Opportunistic Infection
por: Yousuf, Tariq, et al.
Publicado: (2016) -
A Rare Case of Cardiac Tamponade Induced by Chronic Rheumatoid Arthritis
por: Yousuf, Tariq, et al.
Publicado: (2015) -
Impact of Chest Pain Protocol Targeting Intermediate Cardiac Risk Patients in an Observation Unit of an Academic Tertiary Care Center
por: Yousuf, Tariq, et al.
Publicado: (2016) -
Fulminant fat embolism associated with closed fracture reduction.
por: O'Toole, D. P., et al.
Publicado: (1986) -
Survival after Cardiac Arrest Secondary to Massive Pulmonary Embolism
por: Laher, Abdullah E., et al.
Publicado: (2018)